[The vulnerable plaque: a necessary concept in the management of atherothrombosis]

G Rioufol1, G Finet

  • 1Service d'hémodynamique, hôpital cardiovasculaire et pneumologique Louis-Pradel, hospices civils, BP Lyon Montchat, 69394 Lyon. gilles.rioufol@univ-lyon1.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 4, 2003
PubMed

Insights

Identifying vulnerable plaques is key to predicting acute coronary syndrome. Combining biological and morphological approaches offers promising insights for future cardiovascular research and managing atherothrombosis.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Pathology

Context:

  • Atherothrombosis management has advanced, yet global incidence remains high.
  • The unpredictable nature of arterial thrombosis, independent of stenosis severity, poses significant clinical challenges.
  • Current understanding focuses on the role of plaque destabilization, rupture, or erosion in initiating thrombosis.

Purpose:

  • To highlight the critical importance of identifying "vulnerable" atherosclerotic plaques.
  • To explore the morphological and functional criteria of vulnerable plaques.
  • To underscore the predictive value of specific plaque characteristics for acute coronary events.

Summary:

  • Vulnerable plaques, characterized by an inflammatory state, thin fibrous cap, and large lipid core, predict acute coronary syndrome.
  • Anatomopathological findings are increasingly informing clinical understanding of plaque instability.
  • A combined biological and morphological diagnostic strategy is emerging as a crucial area for future research.

Impact:

  • Improved identification of high-risk patients for atherothrombotic events.
  • Potential for earlier and more targeted interventions to prevent acute coronary syndromes.
  • Advancement of clinical research towards integrated diagnostic approaches in cardiology.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...